211 related articles for article (PubMed ID: 16142411)
1. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
2. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
[TBL] [Abstract][Full Text] [Related]
3. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
Ji RC; Eshita Y; Kato S
Int J Exp Pathol; 2007 Aug; 88(4):257-70. PubMed ID: 17696907
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of lymphangiogenic markers in human colorectal cancer.
Parr C; Jiang WG
Int J Oncol; 2003 Aug; 23(2):533-9. PubMed ID: 12851706
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
6. New model of in-situ xenograft lymphangiogenesis by a human colonic adenocarcinoma cell line in nude mice.
Sun JJ; Jing W; Ni YY; Yuan XJ; Zhou HH; Fan YZ
Asian Pac J Cancer Prev; 2012; 13(6):2823-8. PubMed ID: 22938466
[TBL] [Abstract][Full Text] [Related]
7. Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture.
Whitehurst B; Eversgerd C; Flister M; Bivens CM; Pickett B; Zawieja DC; Ran S
Lymphat Res Biol; 2006; 4(3):119-42. PubMed ID: 17034293
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer.
Chutipongpisit K; Parachuru VP; Friedlander LT; Hussaini HM; Rich AM
Int J Exp Pathol; 2021 Dec; 102(6):268-278. PubMed ID: 34791715
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
10. Correlation between lymphatic endothelial markers and lymph node status or N-staging of colorectal cancer.
Zhang XM; Han WX; Wang HY; He Q
World J Surg Oncol; 2017 Nov; 15(1):204. PubMed ID: 29162097
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular mechanisms of lymphangiogenesis.
Al-Rawi MA; Mansel RE; Jiang WG
Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
[TBL] [Abstract][Full Text] [Related]
12. [Effects of three inducing factors on differentiation of bone marrow derived mesenchymal stem cells into lymphatic endothelial cells].
Wang YH; Xue B
Zhonghua Shao Shang Za Zhi; 2019 Feb; 35(2):125-133. PubMed ID: 30798579
[No Abstract] [Full Text] [Related]
13. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action.
Cao R; Björndahl MA; Gallego MI; Chen S; Religa P; Hansen AJ; Cao Y
Blood; 2006 May; 107(9):3531-6. PubMed ID: 16424394
[TBL] [Abstract][Full Text] [Related]
14. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
15. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
[TBL] [Abstract][Full Text] [Related]
16. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
[TBL] [Abstract][Full Text] [Related]
17. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
Davies G; Mason MD; Martin TA; Parr C; Watkins G; Lane J; Matsumoto K; Nakamura T; Jiang WG
Int J Cancer; 2003 Sep; 106(3):348-54. PubMed ID: 12845672
[TBL] [Abstract][Full Text] [Related]
18. Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer.
Wang J; Ma Y; Yang J; Jin L; Gao Z; Xue L; Hou L; Sui L; Liu J; Zou X
J Cell Mol Med; 2019 Mar; 23(3):2219-2229. PubMed ID: 30648805
[TBL] [Abstract][Full Text] [Related]
19. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
[TBL] [Abstract][Full Text] [Related]
20. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]